Nisa Investment Advisors
RLAY icon

Nisa Investment Advisors’s Relay Therapeutics RLAY Stock Holding History

Nisa Investment Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.4K Buy
4,295
+413
+11% +$6K ﹤0.01% 1651
2026
Q1 		$38.6K Buy
3,882
+1,808
+87% +$16.2K ﹤0.01% 1784
2025
Q4 		$17.5K Hold
2,074
– – ﹤0.01% 1987
2025
Q3 		$10.8K Buy
2,074
+59
+3% +$225 ﹤0.01% 2253
2025
Q2 		$6.97K Sell
2,015
-2,769
-58% -$8.24K ﹤0.01% 2385
2025
Q1 		$12.5K Buy
4,784
+3,634
+316% +$14.2K ﹤0.01% 2039
2024
Q4 		$4.74K Sell
1,150
-1,194
-51% -$6.5K ﹤0.01% 2291
2024
Q3 		$16.6K Sell
2,344
-439
-16% -$3.28K ﹤0.01% 1966
2024
Q2 		$18.1K Buy
2,783
+1,878
+208% +$12.8K ﹤0.01% 1980
2024
Q1 		$7.51K Buy
905
+45
+5% +$439 ﹤0.01% 2078
2023
Q4 		$9.47K Sell
860
-2,203
-72% -$18.6K ﹤0.01% 2053
2023
Q3 		$25.8K Buy
3,063
+16
+0.5% +$172 ﹤0.01% 1932
2023
Q2 		$38.3K Buy
3,047
+682
+29% +$8.48K ﹤0.01% 1843
2023
Q1 		$39K Buy
2,365
+25
+1% +$448 ﹤0.01% 1793
2022
Q4 		$35K Sell
2,340
-18
-0.8% -$345 ﹤0.01% 1885
2022
Q3 		$52K Sell
2,358
-685
-23% -$15K ﹤0.01% 1726
2022
Q2 		$51K Buy
3,043
+437
+17% +$9.37K ﹤0.01% 1728
2022
Q1 		$78K Buy
2,606
+20
+0.8% +$485 ﹤0.01% 1711
2021
Q4 		$57K Buy
2,586
+1,457
+129% +$46K ﹤0.01% 1696
2021
Q3 		$36K Sell
1,129
-2,990
-73% -$101K ﹤0.01% 1994
2021
Q2 		$151K Sell
4,119
-540
-12% -$17.8K ﹤0.01% 1511
2021
Q1 		$161K Hold
4,659
– – ﹤0.01% 1549
2020
Q4 		$194K Buy
+4,659
New +$211K ﹤0.01% 1482

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Nisa Investment Advisors's RLAY Position: Q2 2026 in Review

Nisa Investment Advisors increased its Relay Therapeutics (RLAY) stake by 11% in Q2 2026, buying an estimated $6K and bringing the position to 4,295 shares worth $80.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

Nisa Investment Advisors first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. The position peaked at $194K in Q4 2020. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Nisa Investment Advisors held 4,295 shares of Relay Therapeutics worth $80.4K as of Q2 2026.
  • Nisa Investment Advisors bought 413 Relay Therapeutics shares in Q2 2026, an estimated $6K.
  • Relay Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1651 holding.
  • Nisa Investment Advisors first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Nisa Investment Advisors's Relay Therapeutics position peaked at $194K in Q4 2020.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.